Ko M - Search Results

1

LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation.

Sung E, Ko M, Won JY, Jo Y, Park E, Kim H, Choi E, Jung UJ, Jeon J, Kim Y, Ahn H, Choi DS, Choi S, Hong Y, Park H, Lee H, Son YG, Park K, Won J, Oh SJ, Lee S, Kim KP, Yoo C, Song HK, Jin HS, Jung J, Park Y. Sung E, et al. Among authors: ko m. Mol Ther. 2022 Aug 3;30(8):2800-2816. doi: 10.1016/j.ymthe.2022.05.003. Epub 2022 May 6. Mol Ther. 2022. PMID: 35526096 Free PMC article.

2

Extracellular pH modulating injectable gel for enhancing immune checkpoint inhibitor therapy.

Jin HS, Choi DS, Ko M, Kim D, Lee DH, Lee S, Lee AY, Kang SG, Kim SH, Jung Y, Jeong Y, Chung JJ, Park Y. Jin HS, et al. Among authors: ko m. J Control Release. 2019 Dec 10;315:65-75. doi: 10.1016/j.jconrel.2019.10.041. Epub 2019 Oct 25. J Control Release. 2019. PMID: 31669264 Free article.

3

CD226^hiCD8⁺ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.

Jin HS, Ko M, Choi DS, Kim JH, Lee DH, Kang SH, Kim I, Lee HJ, Choi EK, Kim KP, Yoo C, Park Y. Jin HS, et al. Among authors: ko m. Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7. Cancer Immunol Res. 2020. PMID: 32265229

4

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.

Yeo J, Ko M, Lee DH, Park Y, Jin HS. Yeo J, et al. Among authors: ko m. Pharmaceuticals (Basel). 2021 Feb 28;14(3):200. doi: 10.3390/ph14030200. Pharmaceuticals (Basel). 2021. PMID: 33670993 Free PMC article. Review.

5

Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.

Lee DH, Kang SH, Choi DS, Ko M, Choi E, Ahn H, Min H, Oh SJ, Lee MS, Park Y, Jin HS. Lee DH, et al. Among authors: ko m. Cancer Lett. 2021 Jul 10;510:37-47. doi: 10.1016/j.canlet.2021.04.006. Epub 2021 Apr 16. Cancer Lett. 2021. PMID: 33872695

6

Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction.

Kim YS, Jung SH, Park BG, Ko MK, Jang HS, Choi K, Baik JH, Lee J, Lee JK, Pae AN, Cho YS, Min SJ. Kim YS, et al. Eur J Med Chem. 2013 Apr;62:71-83. doi: 10.1016/j.ejmech.2012.12.033. Epub 2012 Dec 26. Eur J Med Chem. 2013. PMID: 23353734

7

Novel thienopyrimidinones as mGluR1 antagonists.

Kim Y, Kim J, Kim S, Ki Y, Seo SH, Tae J, Ko MK, Jang HS, Lim EJ, Song C, Cho Y, Koh HY, Chong Y, Choo IH, Keum G, Min SJ, Choo H. Kim Y, et al. Eur J Med Chem. 2014 Oct 6;85:629-37. doi: 10.1016/j.ejmech.2014.08.027. Epub 2014 Aug 8. Eur J Med Chem. 2014. PMID: 25127154

8

Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model.

Piao C, Zhuang C, Ko MK, Hwang DW, Lee M. Piao C, et al. Among authors: ko mk. J Drug Target. 2022 Aug;30(7):792-799. doi: 10.1080/1061186X.2022.2069781. Epub 2022 Jun 13. J Drug Target. 2022. PMID: 35451894

9

Activated Natural Killer Cell Inoculation Alleviates Fibrotic Liver Pathology in a Carbon Tetrachloride-Induced Liver Cirrhosis Mouse Model.

Oh HR, Ko MK, Son D, Ki YW, Kim SI, Lee SY, Kang KW, Cheon GJ, Hwang DW, Youn H. Oh HR, et al. Biomedicines. 2023 Apr 4;11(4):1090. doi: 10.3390/biomedicines11041090. Biomedicines. 2023. PMID: 37189708 Free PMC article.

10

Neural stem cell delivery using brain-derived tissue-specific bioink for recovering from traumatic brain injury.

Bae M, Hwang DW, Ko MK, Jin Y, Shin WJ, Park W, Chae S, Lee HJ, Jang J, Yi HG, Lee DS, Cho DW. Bae M, et al. Among authors: ko mk. Biofabrication. 2021 Oct 4;13(4). doi: 10.1088/1758-5090/ac293f. Biofabrication. 2021. PMID: 34551404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,989 results

Search Page